Other
TIA
0
Pipeline Programs↗
13
Active Trials↗
23
Companies Involved↗
TIA is an early-stage landscape with 0 programs across 23 companies. The most active players are GSK, AstraZeneca, Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
140
clinical trials
Completed98 · 70%
Unknown status18 · 13%
Recruiting7 · 5%
Terminated6 · 4%
Withdrawn4 · 3%
Active, not recruiting4 · 3%
Other3 · 2%
Clinical Trials
Trial Activity
140 trials
VA Dual Sequential Therapy
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·Phase 4·NCT06929962·600 enrolled
Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men
Active, not recruiting·—·Phase 1·NCT06923839·15 enrolled
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
Active, not recruiting·—·Phase 2·NCT03580928·72 enrolled
ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study
Active, not recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 2·NCT06715592·18 enrolled
Levofloxacin Concomitant Versus Levofloxacin Sequential
Not yet recruiting·—·Phase 4·NCT06065267·150 enrolled
Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition
Completed·—·Phase 1·NCT01566487·54 enrolled
Study to Evaluate Potential Food Effects
Completed·—·Phase 1·NCT00791817·10 enrolled
Page 1 of 10
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)